Cargando…

NETs Lead to Sympathetic Hyperactivity After Traumatic Brain Injury Through the LL37-Hippo/MST1 Pathway

Background: Paroxysmal sympathetic hyperactivity (PSH) is one of the important reasons for the high mortality and morbidity of traumatic brain injury (TBI). We aim to explore the role of the neutrophil extracellular traps (NETs) in the pathogenesis of sympathetic hyperexcitability after TBI and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Kaixin, Zhu, Yibai, Hou, Xiaoxiang, Chen, Wen, Qu, Xiaolin, Zhang, Yelei, Li, Zhenxing, Wang, Chunhui, Chen, Jigang, Lv, Liquan, Wang, Junyu, Zhang, Danfeng, Hou, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116628/
https://www.ncbi.nlm.nih.gov/pubmed/33994918
http://dx.doi.org/10.3389/fnins.2021.621477
_version_ 1783691433737191424
author Zhu, Kaixin
Zhu, Yibai
Hou, Xiaoxiang
Chen, Wen
Qu, Xiaolin
Zhang, Yelei
Li, Zhenxing
Wang, Chunhui
Chen, Jigang
Lv, Liquan
Wang, Junyu
Zhang, Danfeng
Hou, Lijun
author_facet Zhu, Kaixin
Zhu, Yibai
Hou, Xiaoxiang
Chen, Wen
Qu, Xiaolin
Zhang, Yelei
Li, Zhenxing
Wang, Chunhui
Chen, Jigang
Lv, Liquan
Wang, Junyu
Zhang, Danfeng
Hou, Lijun
author_sort Zhu, Kaixin
collection PubMed
description Background: Paroxysmal sympathetic hyperactivity (PSH) is one of the important reasons for the high mortality and morbidity of traumatic brain injury (TBI). We aim to explore the role of the neutrophil extracellular traps (NETs) in the pathogenesis of sympathetic hyperexcitability after TBI and the underlying mechanisms, providing evidence for clinical treatment. Methods: Enzyme-linked immunosorbent assay was used to assess the plasma metanephrine and normetanephrine levels which represented the variation of the sympathetic system after TBI with rat diffuse axonal injury (DAI) model. NETs in the paraventricular nucleus (PVN) and circulating blood were examined using immunofluorescence and flow cytometry. Neutrophils-microglia co-culture system was established to further explore the effect of NETs on PSH and its mechanisms. Results: After TBI, metanephrine and normetanephrine levels began to increase at 9 h and peaked at 72 h. After the injury, the level of NETs kept increasing at 24 and 72 h in the PVN. A positive correlation was found between the concentration of the PVN NETs and blood catecholamine. Flow cytometry of peripheral blood cells revealed that NETs level in the injury group was higher than that in the control group. Immunofluorescence results confirmed the presence of NETs in the PVN after TBI. The positive result of immunoprecipitation suggested a correlation effect between LL37 and P2 × 7. Peptidyl arginine deiminase-4 (PAD4) inhibitor could inhibit the expression levels of MST1, YAP, and IL-1β. The hippo/MST1 pathway inhibitor could inhibit the expression levels of YAP and IL-1β. Conclusion: NETs formation in the PVN might be associated with sympathetic hyperactivity after TBI, which might relate to the activation of microglia cells and increased secretion of IL-1β via the hippo/MST1 pathway.
format Online
Article
Text
id pubmed-8116628
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81166282021-05-14 NETs Lead to Sympathetic Hyperactivity After Traumatic Brain Injury Through the LL37-Hippo/MST1 Pathway Zhu, Kaixin Zhu, Yibai Hou, Xiaoxiang Chen, Wen Qu, Xiaolin Zhang, Yelei Li, Zhenxing Wang, Chunhui Chen, Jigang Lv, Liquan Wang, Junyu Zhang, Danfeng Hou, Lijun Front Neurosci Neuroscience Background: Paroxysmal sympathetic hyperactivity (PSH) is one of the important reasons for the high mortality and morbidity of traumatic brain injury (TBI). We aim to explore the role of the neutrophil extracellular traps (NETs) in the pathogenesis of sympathetic hyperexcitability after TBI and the underlying mechanisms, providing evidence for clinical treatment. Methods: Enzyme-linked immunosorbent assay was used to assess the plasma metanephrine and normetanephrine levels which represented the variation of the sympathetic system after TBI with rat diffuse axonal injury (DAI) model. NETs in the paraventricular nucleus (PVN) and circulating blood were examined using immunofluorescence and flow cytometry. Neutrophils-microglia co-culture system was established to further explore the effect of NETs on PSH and its mechanisms. Results: After TBI, metanephrine and normetanephrine levels began to increase at 9 h and peaked at 72 h. After the injury, the level of NETs kept increasing at 24 and 72 h in the PVN. A positive correlation was found between the concentration of the PVN NETs and blood catecholamine. Flow cytometry of peripheral blood cells revealed that NETs level in the injury group was higher than that in the control group. Immunofluorescence results confirmed the presence of NETs in the PVN after TBI. The positive result of immunoprecipitation suggested a correlation effect between LL37 and P2 × 7. Peptidyl arginine deiminase-4 (PAD4) inhibitor could inhibit the expression levels of MST1, YAP, and IL-1β. The hippo/MST1 pathway inhibitor could inhibit the expression levels of YAP and IL-1β. Conclusion: NETs formation in the PVN might be associated with sympathetic hyperactivity after TBI, which might relate to the activation of microglia cells and increased secretion of IL-1β via the hippo/MST1 pathway. Frontiers Media S.A. 2021-04-29 /pmc/articles/PMC8116628/ /pubmed/33994918 http://dx.doi.org/10.3389/fnins.2021.621477 Text en Copyright © 2021 Zhu, Zhu, Hou, Chen, Qu, Zhang, Li, Wang, Chen, Lv, Wang, Zhang and Hou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Zhu, Kaixin
Zhu, Yibai
Hou, Xiaoxiang
Chen, Wen
Qu, Xiaolin
Zhang, Yelei
Li, Zhenxing
Wang, Chunhui
Chen, Jigang
Lv, Liquan
Wang, Junyu
Zhang, Danfeng
Hou, Lijun
NETs Lead to Sympathetic Hyperactivity After Traumatic Brain Injury Through the LL37-Hippo/MST1 Pathway
title NETs Lead to Sympathetic Hyperactivity After Traumatic Brain Injury Through the LL37-Hippo/MST1 Pathway
title_full NETs Lead to Sympathetic Hyperactivity After Traumatic Brain Injury Through the LL37-Hippo/MST1 Pathway
title_fullStr NETs Lead to Sympathetic Hyperactivity After Traumatic Brain Injury Through the LL37-Hippo/MST1 Pathway
title_full_unstemmed NETs Lead to Sympathetic Hyperactivity After Traumatic Brain Injury Through the LL37-Hippo/MST1 Pathway
title_short NETs Lead to Sympathetic Hyperactivity After Traumatic Brain Injury Through the LL37-Hippo/MST1 Pathway
title_sort nets lead to sympathetic hyperactivity after traumatic brain injury through the ll37-hippo/mst1 pathway
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116628/
https://www.ncbi.nlm.nih.gov/pubmed/33994918
http://dx.doi.org/10.3389/fnins.2021.621477
work_keys_str_mv AT zhukaixin netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT zhuyibai netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT houxiaoxiang netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT chenwen netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT quxiaolin netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT zhangyelei netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT lizhenxing netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT wangchunhui netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT chenjigang netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT lvliquan netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT wangjunyu netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT zhangdanfeng netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway
AT houlijun netsleadtosympathetichyperactivityaftertraumaticbraininjurythroughthell37hippomst1pathway